Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 559

1.

Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.

Yang J, Liu H, Wang H, Sun Y.

Pathol Res Pract. 2013 Aug;209(8):490-4. doi: 10.1016/j.prp.2013.04.018. Epub 2013 Jun 6.

PMID:
23827213
[PubMed - indexed for MEDLINE]
2.

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX.

BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519.

PMID:
23151088
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.

Xu T, Liu X, Han L, Shen H, Liu L, Shu Y.

Clin Transl Oncol. 2014 May;16(5):469-75. doi: 10.1007/s12094-013-1106-1. Epub 2013 Sep 10.

PMID:
24019037
[PubMed - indexed for MEDLINE]
4.

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.

Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W.

J Surg Oncol. 2011 Dec;104(7):847-51. doi: 10.1002/jso.22008. Epub 2011 Jun 30.

PMID:
21721011
[PubMed - indexed for MEDLINE]
5.

Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.

Lin Q, Chen T, Lin Q, Lin G, Lin J, Chen G, Guo L.

J Surg Oncol. 2013 Jun;107(7):767-71. doi: 10.1002/jso.23312. Epub 2013 Apr 23.

PMID:
23609137
[PubMed - indexed for MEDLINE]
6.

The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts.

Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A, Harris CC.

Clin Cancer Res. 2011 Apr 1;17(7):1875-82. doi: 10.1158/1078-0432.CCR-10-2961. Epub 2011 Feb 24.

PMID:
21350005
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Analysis of MAT3 gene expression in NSCLC.

Zheng S, Du Y, Chu H, Chen X, Li P, Wang Y, Ma Y, Wang H, Zang W, Zhang G, Zhao G.

Diagn Pathol. 2013 Oct 9;8:166. doi: 10.1186/1746-1596-8-166.

PMID:
24107548
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
[PubMed - indexed for MEDLINE]
9.

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):953-7. doi: 10.1097/MEG.0b013e32835ed691.

PMID:
23751352
[PubMed - indexed for MEDLINE]
10.

MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met.

Luo W, Huang B, Li Z, Li H, Sun L, Zhang Q, Qiu X, Wang E.

PLoS One. 2013 May 29;8(5):e64759. doi: 10.1371/journal.pone.0064759. Print 2013.

PMID:
23734217
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.

Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK.

Med Oncol. 2012 Jun;29(2):618-26. doi: 10.1007/s12032-011-9923-y. Epub 2011 Apr 24.

PMID:
21516486
[PubMed - indexed for MEDLINE]
12.

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.

Wang S, Xue S, Dai Y, Yang J, Chen Z, Fang X, Zhou W, Wu W, Li Q.

Diagn Pathol. 2012 Nov 22;7:159. doi: 10.1186/1746-1596-7-159.

PMID:
23173870
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

PMID:
20363096
[PubMed - indexed for MEDLINE]
14.

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.

Luo L, Zhang T, Liu H, Lv T, Yuan D, Yao Y, Lv Y, Song Y.

Med Oncol. 2012 Sep;29(3):1681-6. doi: 10.1007/s12032-011-0085-8. Epub 2011 Oct 13.

PMID:
21993632
[PubMed - indexed for MEDLINE]
15.

Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.

Kim MK, Jung SB, Kim JS, Roh MS, Lee JH, Lee EH, Lee HW.

Virchows Arch. 2014 Oct;465(4):463-71. doi: 10.1007/s00428-014-1640-4. Epub 2014 Aug 16.

PMID:
25124149
[PubMed - indexed for MEDLINE]
16.

Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.

Võsa U, Vooder T, Kolde R, Fischer K, Välk K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A, Annilo T.

Genes Chromosomes Cancer. 2011 Oct;50(10):812-22. doi: 10.1002/gcc.20902. Epub 2011 Jul 11.

PMID:
21748820
[PubMed - indexed for MEDLINE]
17.

Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.

Li ZH, Zhang H, Yang ZG, Wen GQ, Cui YB, Shao GG.

J Int Med Res. 2013 Oct;41(5):1437-44. doi: 10.1177/0300060513497560. Epub 2013 Sep 24.

PMID:
24065453
[PubMed - indexed for MEDLINE]
18.

Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.

Zhan P, Shen XK, Qian Q, Wang Q, Zhu JP, Zhang Y, Xie HY, Xu CH, Hao KK, Hu W, Xia N, Lu GJ, Yu LK.

Oncol Rep. 2012 Apr;27(4):1072-8. doi: 10.3892/or.2011.1605. Epub 2011 Dec 21.

PMID:
22200856
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.

Eur J Surg Oncol. 2012 Jun;38(6):523-30. doi: 10.1016/j.ejso.2012.02.180. Epub 2012 Mar 21.

PMID:
22440742
[PubMed - indexed for MEDLINE]
20.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.

Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS.

J Thorac Cardiovasc Surg. 2012 Oct;144(4):794-807. doi: 10.1016/j.jtcvs.2012.06.030. Epub 2012 Jul 18.

PMID:
22818121
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk